Holen Sie sich die Stockscreener-App
10.33
2.09%
-0.22
Handel nachbörslich:
10.33
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$10.55
Offen:
$10.51
24-Stunden-Volumen:
7.03M
Relative Volume:
0.63
Marktkapitalisierung:
$12.04B
Einnahmen:
$14.33B
Nettoeinkommen (Verlust:
$-3.79B
KGV:
-3.2587
EPS:
-3.17
Netto-Cashflow:
$1.84B
1W Leistung:
-0.77%
1M Leistung:
+15.55%
6M Leistung:
+10.25%
1J Leistung:
-12.31%
1-Tages-Spanne:
$10.29
$10.54
1-Wochen-Bereich:
$10.29
$10.61
52-Wochen-Spanne:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Firmenname
Viatris Inc
Sektor
Telefon
(724) 514-1465
Adresse
1000 MYLAN BOULEVARD, CANONSBURG
Vergleichen Sie VTRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.33 | 12.31B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-06 | Eingeleitet | Goldman | Neutral |
| 2024-07-19 | Fortgesetzt | Jefferies | Buy |
| 2023-10-23 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-06-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-04-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-02-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-10 | Hochstufung | UBS | Sell → Neutral |
| 2022-11-08 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | Fortgesetzt | Jefferies | Hold |
| 2022-06-14 | Eingeleitet | UBS | Sell |
| 2022-05-10 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-03-01 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | Eingeleitet | Citigroup | Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-03-08 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | Eingeleitet | Argus | Hold |
| 2020-12-14 | Eingeleitet | Bernstein | Mkt Perform |
Alle ansehen
Viatris Inc Aktie (VTRS) Neueste Nachrichten
Candlestick signals on Viatris Inc. stock todayQuarterly Trade Summary & Community Consensus Trade Alerts - Newser
How volatile is Viatris Inc. stockGDP Growth & Weekly Return Optimization Plans - khodrobank.com
Stock Analysis | Viatris OutlookMixed Signals Amid Regulatory Shifts and Weak Technicals - AInvest
Risk adjusted return profile for Viatris Inc. analyzedGold Moves & Verified Momentum Stock Alerts - Newser
Will a bounce in Viatris Inc. offer an exitRate Cut & Low Risk Growth Stock Ideas - Newser
Is Viatris Inc. reversing from oversold territoryJuly 2025 Intraday Action & Long-Term Investment Growth Plans - Newser
How moving averages guide Viatris Inc. trading2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Using fundamentals and technicals on Viatris Inc.Earnings Recap Report & Expert Approved Momentum Trade Ideas - Newser
How to escape a deep drawdown in Viatris Inc.Weekly Trade Report & Weekly Breakout Watchlists - Newser
Evaluating Viatris Inc. with trendline analysisEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser
Statistical indicators supporting Viatris Inc.’s strengthStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Can machine learning forecast Viatris Inc. recovery2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
When is the best time to exit Viatris Inc.2025 Market Overview & Safe Entry Momentum Stock Tips - Newser
Using data tools to time your Viatris Inc. exitJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Can Viatris Inc. recover in the next quarterCPI Data & Expert Approved Momentum Ideas - Newser
What are the risks of holding Viatris Inc.Weekly Risk Summary & Low Volatility Stock Suggestions - خودرو بانک
What high frequency data says about Viatris Inc.2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - Newser
How to use Fibonacci retracement on Viatris Inc.Portfolio Performance Report & Technical Pattern Based Signals - Newser
Can Viatris Inc. deliver consistent EPS growthJuly 2025 Review & Stepwise Trade Signal Guides - khodrobank.com
Is Viatris Inc. stock a top performer YTDJuly 2025 Review & Real-Time Stock Movement Alerts - خودرو بانک
Can Viatris Inc. navigate macro headwindsQuarterly Investment Review & Free Daily Entry Point Trade Alerts - خودرو بانک
Analyzing recovery setups for Viatris Inc. investorsMarket Performance Report & Advanced Technical Signal Analysis - Newser
Epinephrine Market to Size to Reach USD 5.74 Billion by 2032 as Demand for Emergency Allergy Treatments Surges – SNS Insider - GlobeNewswire Inc.
Using economic indicators to assess Viatris Inc. potentialMarket Trend Report & High Return Trade Guides - Newser
Real time pattern detection on Viatris Inc. stockWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Advanced analytics toolkit walkthrough for Viatris Inc.Forecast Cut & Low Drawdown Momentum Trade Ideas - Newser
Combining machine learning predictions for Viatris Inc.Quarterly Trade Review & High Accuracy Trade Alerts - Newser
Why Viatris Inc. stock attracts strong analyst attentionMarket Weekly Review & Low Risk Growth Stock Ideas - Newser
What to expect from Viatris Inc. in the next 30 days2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Should you hold or exit Viatris Inc. nowIPO Watch & Fast Moving Market Watchlists - Newser
Applying Wyckoff theory to Viatris Inc. stockBond Market & Real-Time Stock Movement Alerts - Newser
How to use a screener to detect Viatris Inc. breakoutsWeekly Trade Summary & Real-Time Buy Signal Notifications - Newser
Intraday pattern recognizer results for Viatris Inc.Market Weekly Review & Community Supported Trade Ideas - Newser
Can Viatris Inc. rally from current levelsMarket Growth Report & Fast Moving Stock Trade Plans - Newser
Key resistance and support levels for Viatris Inc.July 2025 Intraday Action & Daily Stock Trend Reports - Newser
Published on: 2025-08-31 00:24:18 - Newser
Using Bollinger Bands to evaluate Viatris Inc.July 2025 PostEarnings & Technical Confirmation Alerts - Newser
Published on: 2025-08-30 20:52:18 - Newser
What high frequency data says about Viatris Inc2025 Growth vs Value & AI Powered Market Entry Strategies - Newser
Finanzdaten der Viatris Inc-Aktie (VTRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Viatris Inc-Aktie (VTRS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Smith Scott Andrew | Chief Executive Officer |
May 12 '25 |
Buy |
8.94 |
60,000 |
536,262 |
292,807 |
| Le Goff Corinne | Chief Commercial Officer |
Apr 15 '25 |
Option Exercise |
0.00 |
41,112 |
0 |
60,441 |
| FINNEY ELISHA W | Director |
Mar 04 '25 |
Option Exercise |
0.00 |
18,977 |
0 |
37,832 |
| Le Goff Corinne | Chief Commercial Officer |
Mar 04 '25 |
Option Exercise |
0.00 |
37,894 |
0 |
36,721 |
| Campbell Paul | See Remarks |
Mar 04 '25 |
Option Exercise |
0.00 |
207,325 |
0 |
328,250 |
| Campbell Paul | See Remarks |
Mar 03 '25 |
Option Exercise |
0.00 |
19,348 |
0 |
144,590 |
| Vivaldi Coelho Rogerio | Director |
Mar 04 '25 |
Option Exercise |
0.00 |
21,691 |
0 |
21,691 |
| Smith Scott Andrew | Chief Executive Officer |
Mar 04 '25 |
Option Exercise |
0.00 |
96,431 |
0 |
266,825 |
| Smith Scott Andrew | Chief Executive Officer |
Mar 03 '25 |
Option Exercise |
0.00 |
146,700 |
0 |
221,178 |
| PARRISH MARK W | Director |
Mar 04 '25 |
Option Exercise |
0.00 |
18,977 |
0 |
140,395 |
0.28%
3.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):